Skip to main content
. 2017 Dec 17;12(1):47–52. doi: 10.1177/1932296817747617

Table 3.

Outcome Measures.

PBP (n = 27) eGMS (n = 27) P value
Primary outcome
Incidence of hypoglycemia (BG < 70 mg/dL), %BG per patient days on infusion 21.46 1.27 <.0001
 Severe hypoglycemia (BG < 40 mg/dL) 5.37 0.01 <.0001
Number of hypoglycemic episodes per patient, mean (range) 1.5 (1-5) 1.1 (1-2) .01
BG for hypoglycemic event, mean ± SD 55.2 ± 12.5 (18-69) 53.4 ± 12.5 (32-69) .1
Secondary outcomes
Time in target (BG 110-180 mg/dl), %BG per patient days 31.52 63.71 <.0001
Hyperglycemia (BG > 180 mg/dl), %BG per patient day 27.81 25.29 .47
BG variability, %BG per patient days <70 mg/dl or >180 mg/dl 49.27% 26.56% .001
ICU LOS in days, median (IQR) 3.63 (5.10) 3.18 (4.23)
Hospital LOS in days, median (IQR) 7.86 (7.14) 6.07 (11.5)
Other outcomes
Prior to hypoglycemic event
 Days on infusion, mean ± SD 4.1 ± 4.9 2.5 ± 2.97 .01
 Time to event from last BG check, hoursa 2.5 ± 1.0 1.5 ± 0.5 .001
 Last BG value prior to event, mean ± SD 134.1 ± 48.8 105.3 ± 46.5 .001
a

Rounded to nearest 0.5 hour.